High blood pressure, or hypertension, is a common condition that affects millions of people globally. It significantly ...

A soon-to-be-published study analyzed more than 6 million patient records to help support a growing link between heart and ...

Duke-NUS scientists and their collaborators have discovered a potential new treatment for heart failure with preserved ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other best healthcare stocks to buy according to hedge funds. Resilience and Growth in the U.S.

In 2022, nearly 619,000 global deaths due to malaria ... Irvine and Yale School of Medicine all in the United States has now designed a new drug against malaria and identified its mechanism ...

WASHINGTON - Experts expressed enthusiasm after US health regulators approved the first new form of treatment for schizophrenia in decades. The drug, called Cobenfy and developed by US pharma ...

The US Food and Drug Administration has approved a new drug for schizophrenia. The drug, known as KarXT or Cobenfy, belongs to Bristol Myers Squibb. Bristol Myers got the drug via its $14 billion ...

has revealed promising results for a new medication called zilebesiran, which could become an important treatment option for people with high blood pressure (hypertension). The study was led by Dr ...

Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in decades. The drug, called Cobenfy and developed by US pharma giant ...

WASHINGTON, D.C. — Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in decades. The drug, called Cobenfy and developed by US ...

A new drug has ... In terms of safety, the medication’s most common side effects during clinical trials were nausea, indigestion, vomiting, diarrhea, constipation, hypertension, abdominal ...

People with schizophrenia will have a new treatment option for the first time in more than three decades, after the Food and Drug Administration Thursday approved a new kind of drug. Studies ...